Article Text

PDF

Clinical studies in obstructive sleep apnoea
P199 Diabetic macular oedema (DME) and obstructive sleep apnoea (OSA)—visual improvement post CPAP therapy. Proof of principle study
  1. R H Mason1,
  2. C A Kiire2,
  3. A Bolton2,
  4. L Smith2,
  5. V Chong2,
  6. J R Stradling1
  1. 1Oxford Sleep Unit, The Churchill Hospital, Oxford, UK
  2. 2The Eye Hospital, Oxford, UK

Abstract

Introduction and Objectives DME is an important cause of visual loss and is more advanced in patients with coexistent OSA.1OSA is very common in individuals with DME (54%), compared to unselected patients with type II diabetes (23%)2 and age matched controls (8%).3 This study was designed to see if CPAP could improve vision in patients with DME and coexistent OSA, perhaps via a reduction in intermittent hypoxia and/or blood pressure oscillations.

Methods 35 patients with DME (identified by ocular coherence tomography, OCT) and OSA (oxygen desaturation index >10, or apnoea hypopnoea index >15) were identified. Visual acuity (VA, logMAR, similar to the Snellen chart) and OCT measurements were made twice at baseline (pre-CPAP), 3 and 6 months (post-CPAP).

Results 32 patients (17 males) participated; 4 withdrew. 28 have 3-month follow-up data and, 24 have 6-month data. Average (SD) age 66.6 years, (8.3), BMI 31.8 Kg/m2 (6.7), HbA1c 7.5% (1.4%), ESS 7.9 (4.6), ODI 20.9 (14.8) and AHI 19.0(14.5). CPAP compliance was averaged over the 6 months and a median split into ‘high’ and ‘low’ compliers performed (> and <2.5 h/n). At 3 months VA improved significantly in both high (p=0.009) and low compliers (p=0.001). This was only sustained at 6 months in high compliers, p=0.004. (Low compliers p=0.52). There was no significant reduction in macular oedema at either 3 or n.

Conclusions This hypothesis-generating uncontrolled study indicates that continued use of CPAP in individuals with DME and OSA was associated with sustained improvement in visual acuity. This result provides justification to perform an RCT and suggests that logMAR should be the primary endpoint whereas OCT measurements appear uninformative.

Abstract P199 Figure 1

LogMAR after CPAP use, high versus low compliers (mean ± SEM).

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.